Press Release | Honored as One of the PharmaVOICE 100 Most Inspiring Leaders in Life Sciences

ProTrials Research, Inc., a mid-sized clinical research organization (CRO), specializing in the delivery of clinical operations services to the pharmaceutical, biotechnology, and medical device industries announced today that company Founder and Co-CEO Inger Arum was named to the 2020 PharmaVOICE 100.

PharmaVOICE magazine this week released its annual list highlighting the 100 most inspiring individuals in the life sciences industry as identified by our international community.  The list recognizes impact player Inger Arum who has helped set the course and vision for the future of life sciences.

Since its founding in 1996, ProTrials has had a reputation for providing clinical service excellence and client satisfaction to the biopharmaceutical industry.  With co-Founder and co-CEO Jodi Andrews, Inger has led the company successfully for the past 24 years.  Before founding ProTrials, Inger spent over a decade at Syntex Pharmaceuticals, where she specialized in clinical operations and managed multinational studies in diverse therapeutic programs.  After the acquisition, Inger moved into global operations with the UK division of Roche to direct international HIV trial teams.  Inger has been named one of Silicon Valley’s most influential businesswomen by the Silicon Valley Business Journal and recognized by CenterWatch as the leader of one of the fastest growing specialty contract research organizations in North America.

From the start, Inger has fostered a culture focused on excellence and community. Through her direction, ProTrials was one of the first clinical research organizations in the country to adopt eco-sensitivity initiatives. Under her leadership ProTrials has supported groundbreaking therapeutic trials in AMD, HIV, and oncology indications.  ”Inger leads by example and is a pioneer in the clinical research industry, having established one of the first and only certified woman-owned clinical research organizations,” notes Matt Smith, ProTrials’ Chief Revenue Officer.  “We are pleased to acknowledge this PharmaVOICE 100 award and congratulate Inger for this honor.”